FDA Inspection
Sunshine Lake Pharma Co., LtdSunshine Lake Pharma Co., Ltd – FDA Inspection, Oct 19, 2017
Record Details
This FDA Inspection record concerns Sunshine Lake Pharma Co., Ltd, with an inspection on October 19, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b24155be-7eb1-42da-987e-8030717615c1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1030492
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Sunshine Lake Pharma Co., Ltd
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 9, 2019 | Not classified | Office of Inspections and Investigations | |
| January 25, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| March 16, 2018 | Not classified | Office of Inspections and Investigations | |
| September 25, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sunshine Lake Pharma Co., Ltd
- FDA Inspection 1236240 - 2024-03-22
- FDA Inspection 1106395 - 2019-08-09
- FDA Inspection 1078090 - 2019-01-25
- FDA Inspection 1046748 - 2018-03-16
- FDA Inspection 945450 - 2015-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.